| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
TORON: AKL |
| Security Type |
Common Stock |
| Lead Underwriter |
Lazard Capital Markets |
| Days In Registration |
98 |
| Date Filed |
12-Oct-2007 |
| Form Filed | F-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Akela Pharma Inc is a manufacturer of pharmaceutical, headquartered in St-Laurent, Quebec. The company develops therapies for the inhalation and pain markets. The company was founded in 1998. |
| Revenue |
$13.4M |
| Net Income |
-$34.8M |
| Shares Outstanding (post-offering) |
17.02M |
| Contact |
- |
| Number of Employees |
390 |
|
| Original Filing Information |
| US |
| Shares Filed |
5.25M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
787.5K |
| File Amount |
- |
| File Price Range |
$8.00 - $6.00 |
| File Mid Price |
$7.00 |
|
